Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-20

Clinical Trial Update: Effectiveness of Melatonin for Sleep Disturbances in Children With Atopic Dermatitis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial evaluating the effectiveness of melatonin to improve sleep disturbances in children with atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Atopic Dermatitis | Phase 2, Phase 3 | Status: COMPLETED